223 related articles for article (PubMed ID: 20416304)
1. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Dong X; Javle M; Hess KR; Shroff R; Abbruzzese JL; Li D
Gastroenterology; 2010 Aug; 139(2):464-73, 473.e1-3. PubMed ID: 20416304
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.
Dong X; Li Y; Tang H; Chang P; Hess KR; Abbruzzese JL; Li D
Cancer Epidemiol; 2012 Apr; 36(2):206-11. PubMed ID: 21852217
[TBL] [Abstract][Full Text] [Related]
3. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
Schirripa M; Zhang W; Heinemann V; Cao S; Okazaki S; Yang D; Loupakis F; Berger MD; Ning Y; Miyamoto Y; Suenaga M; Gopez RF; West JD; Hanna D; Barzi A; Falcone A; Stintzing S; Lenz HJ
Int J Cancer; 2017 Jul; 141(2):383-392. PubMed ID: 28369940
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX.
Oh SY; Shin A; Kim SG; Hwang JA; Hong SH; Lee YS; Kwon HC
Oncotarget; 2016 May; 7(21):31204-14. PubMed ID: 27144430
[TBL] [Abstract][Full Text] [Related]
6. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
Neuhausen SL; Brummel S; Ding YC; Singer CF; Pfeiler G; Lynch HT; Nathanson KL; Rebbeck TR; Garber JE; Couch F; Weitzel J; Narod SA; Ganz PA; Daly MB; Godwin AK; Isaacs C; Olopade OI; Tomlinson G; Rubinstein WS; Tung N; Blum JL; Gillen DL
Breast Cancer Res; 2009; 11(5):R76. PubMed ID: 19843326
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women.
Sweeney C; Murtaugh MA; Baumgartner KB; Byers T; Giuliano AR; Herrick JS; Wolff R; Caan BJ; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1802-9. PubMed ID: 16030120
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.
Neuhausen SL; Slattery ML; Garner CP; Ding YC; Hoffman M; Brothman AR
Prostate; 2005 Jul; 64(2):168-74. PubMed ID: 15678496
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.
Saracevic A; Nikolac N; Reljic A; Simundic AM
Genet Test Mol Biomarkers; 2011 Mar; 15(3):127-31. PubMed ID: 21204696
[TBL] [Abstract][Full Text] [Related]
12. Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration.
Chiu CJ; Conley YP; Gorin MB; Gensler G; Lai CQ; Shang F; Taylor A
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9099-107. PubMed ID: 22058336
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer.
Suzuki H; Li Y; Dong X; Hassan MM; Abbruzzese JL; Li D
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3467-73. PubMed ID: 19064563
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.
Hirakawa T; Yashiro M; Murata A; Hirata K; Kimura K; Amano R; Yamada N; Nakata B; Hirakawa K
BMC Cancer; 2013 Aug; 13():392. PubMed ID: 23962053
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
[TBL] [Abstract][Full Text] [Related]
16. Association of insulin receptor H1085H C>T, insulin receptor substrate 1 G972R and insulin receptor substrate 2 1057G/A polymorphisms with refractory temporal lobe epilepsy in Han Chinese.
Che F; Fu Q; Li X; Gao N; Qi F; Sun Z; Du Y; Li M
Seizure; 2015 Feb; 25():178-80. PubMed ID: 25458098
[TBL] [Abstract][Full Text] [Related]
17. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.
Reid-Lombardo KM; Fridley BL; Bamlet WR; Cunningham JM; Sarr MG; Petersen GM
Ann Surg; 2013 Jun; 257(6):1096-102. PubMed ID: 23360921
[TBL] [Abstract][Full Text] [Related]
18. Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.
LeRoy EC; Moore JH; Hu C; Martínez ME; Lance P; Duggan D; Thompson PA
Hum Genet; 2011 May; 129(5):503-12. PubMed ID: 21221997
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
[TBL] [Abstract][Full Text] [Related]
20. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
